CST BLOG: Lab Expectations

The official blog of Cell Signaling Technology (CST), where we discuss what to expect from your time at the bench, share tips, tricks, and information.

Targeting Cancer Pathways - Tumor Metabolism and Proliferation

Read More
All Posts

Cell Signaling Technology is proud to partner with the Koch Institute at MIT, Science, and Science Signaling to present the Targeting Cancer Pathways webinar series. These webinars will bring together thought leaders from around the world to share current findings and further cancer research community collaboration.

In this webinar, we will explore how cancer cells are able to reprogram their metabolic pathways to enable energy production under conditions that are disabling to most normal cells. Of great interest are how tumor-specific metabolic changes promote oncogenic progression and how these changes can be exploited to develop more effective treatment options.

During the webinar, the speakers will:

  • Outline the major metabolic changes seen in tumor tissue
  • Explain how specific metabolic pathways can be targeted during therapeutic interventions
  • Introduce the role of autophagy and cell death in tumor survival and progression

Featured speakers:

Nissim Hay, Ph.D
University of Illinois
Chicago, IL

M. Celeste Simon, Ph.D.
University of Pennsylvania
Philadelphia, PA

Webinar - Targeting Cancer Pathways: Tumor Metabolism and Proliferation

 

Webinar - Targeting Cancer Pathways: Tumor Metabolism and Proliferation | Cell Signaling Technology

Browse more on-demand webinars on our Videos and Webinars page.

 

CancerPoster2013-sm5

 

Recent Posts

Microglial Activation Antibody Toolkit: High-Content Methods to Study TREM2 Signaling

Selecting antibodies for molecular signaling research in neurodegeneration is a complex and nuanced proce...
Ginny Bain, PhD Dec 11, 2024

Cell Preparation Tips for Accurate Flow Cytometry Data

Generating accurate flow cytometry data requires more than just specific and sensitive antibodies validat...
Andrea Tu, PhD Nov 20, 2024

500 Antibodies & Counting: Accelerating Discovery with CST Antibodies Validated for Simple Western Technology

Since 2022, Cell Signaling Technology (CST) and Bio-Techne have been working together to bring best-in-cl...
Chris LaBreck, PhD Oct 23, 2024